AbbVie EPS - Earnings per Share 2012-2026 | ABBV

AbbVie earnings per share (EPS) for the twelve months ending March 31, 2026 was $2.03, a 13.25% decline year-over-year.

  • AbbVie EPS for the quarter ending March 31, 2026 was $0.39, a 45.83% decline year-over-year.
  • AbbVie 2025 annual EPS was $2.36, a 1.26% decline from 2024.
  • AbbVie 2024 annual EPS was $2.39, a 12.13% decline from 2023.
  • AbbVie 2023 annual EPS was $2.72, a 58.97% decline from 2022.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

AbbVie EPS - Earnings per Share 2012-2026 | ABBV

  • AbbVie EPS for the quarter ending March 31, 2026 was $0.39, a 45.83% decline year-over-year.
  • AbbVie 2025 annual EPS was $2.36, a 1.26% decline from 2024.
  • AbbVie 2024 annual EPS was $2.39, a 12.13% decline from 2023.
  • AbbVie 2023 annual EPS was $2.72, a 58.97% decline from 2022.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B